Chidamide Combined with NKG2D CAR-NK Cell Therapy
HCIT-001
Phase 2 small_molecule active
Quick answer
Chidamide Combined with NKG2D CAR-NK Cell Therapy for HIV (Human Immunodeficiency Virus) is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- HIV (Human Immunodeficiency Virus)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active